MassRoots

JANUARY 10, 2019

House Bill 136, an amendment to legalize medical marijuana, was introduced in the Kentucky Legislature on Wednesday, January 9, 2019. Lawmakers have been listening to constituents suffering from debilitating diseases, like epilepsy and cancer, who say they would like to have the option to explore how medical cannabis may ease their symptoms.

Legalization 111

Legalization Marijuana Epilepsy Legislation 111

The Cannigma

JUNE 1, 2021

The plan was initially passed in 2019 but was delayed multiple times, including because of the COVID-19 pandemic. Some of the qualifying health conditions include epilepsy, neuropathic pain, chemotherapy side effects, a need for palliative care, and pain linked to multiple sclerosis, according to France24.

Law 119

Law Epilepsy Programs Patients 119

Project CBD

MARCH 21, 2023

I nterestingly, and perhaps unfortunately for patients, previous reviews in 2020 and 2019 2 also concluded there was insufficient evidence that cannabis can diminish chronic tinnitus. 32,1 (2019): 131-136. Despite all this, there is a potential biological rationale for the treatment of tinnitus with cannabinoids, the authors explain.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

MJ Business Attorneys

JULY 29, 2019

As of right now, the only cannabis-based medication officially recognized by the FDA is the CBD oral solution Epidiolex, which is used to treat two rare forms of childhood-onset epilepsy. The FDA is currently in the process of reviewing CBD and plans to release a report on the progress around the fall of 2019.

CBD 133

CBD Pets Media Food 133

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. References Staff, T.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

MARCH 29, 2019

Chad West March 27, 2019. Texas could make meaningful progress on marijuana-related bills by the end of the 2019 legislative session. Currently, only epilepsy patients may use the drug produced at three state facilities. If passed, H.B. Stephanie Klick, R-Fort Worth. If passed, H.B. 2416 – Sen.

Epilepsy 45

Epilepsy Law Chronic Pain Programs 45

The Cannigma

MAY 19, 2021

In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes. Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition.

Law 145

Law Legalization Clinical Trials CBD 145

Veriheal

NOVEMBER 18, 2022

Back in 2019 , the program was expanded to include ALL individuals with epilepsy—not just those with intractable epilepsy as the program had originally outlined. In September, the state expanded its list of qualifying conditions , allowing veterans with PTSD and cancer patients to join the program.

Edibles 98

Edibles Hemp Epilepsy Programs 98

Illinois News Joint

JULY 31, 2024

Conditions include: Autism Agitation of Alzheimer’s disease HIV/AIDS Amyotrophic lateral sclerosis (ALS) Anorexia nervosa Arnold-Chiari malformation Cancer Cachexia/wasting syndrome Causalgia Chronic inflammatory demyelinating polyneuropathy Chronic pain Crohn’s disease CRPS (complex regional pain syndrome Type II) Dystonia Ehlers-Danlos syndrome Fibrous (..)

Conditions 105

Conditions Chronic Pain Patients Epilepsy 105

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m. PT (2:00 p.m.

Pharmaceutical 51

Pharmaceutical Clinical Trials Research and Development Programs 51

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data.

THC 111

THC CBD Data Cannabinoids 111

Cannabis Law Report

MARCH 21, 2019

THC for patients who suffer from severe epilepsy and is produced in compliance with the North Carolina Industrial Hemp Commission regulations. Wyoming has legalized CBD use but only for patients with epilepsy who have been unsuccessfully treated with various alternatives. North Carolina has legalized CBD containing less than 0.3%

State Laws 55

State Laws Law CBD Legalization 55

MassRoots

AUGUST 3, 2020

Louisiana’s medical marijuana program may have been established three years ago, but patients were not granted access to medicine until August of 2019 when the first round of the product became available. Home cultivation remains illegal for the more than 4,000 registered medical marijuana patients. House Bill 418.

Programs 124

Programs Banking Marijuana Conditions 124

Illinois News Joint

JANUARY 9, 2025

The four approvals mark the first expansion of the list of conditions that can be treated with medical cannabis since 2019. Providers are now able to begin certifying patients with those conditions for treatment with medical cannabis. Those four newly added conditions bring the total to 56.

Conditions 105

Conditions Treatment Chronic Pain Epilepsy 105

MassRoots

FEBRUARY 17, 2019

— Senator Jay Costa (@Senatorcosta) February 15, 2019. In its first year of operation, Pennsylvania's medical marijuana program helped 83,000 folks access medication, dispensed from nearly 600,000 times at approved dispensaries across the state. Clearly this was a serious need in the Commonwealth.

Marijuana 105

Marijuana Programs Dispensary Collective 105

Cannabis Law Report

AUGUST 19, 2021

Britain’s Food Standards Agency now regulates the sector and its marketing, after the European Union classified CBD as food in 2019. That was almost a third higher than the UK trade group’s pre-pandemic 2019 projection. “I’ve seen thousands of people’s lives changed.

Cannabinoids 105

Cannabinoids Seed-To-Sale Clinical Trials CBD 105

Project CBD

FEBRUARY 28, 2023

Sales appear to have peaked in 2019, when natural channel consumers spent more than $90.7 FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy [press release]. Epilepsy Behav. In 2021, CBD sales in the natural channel totaled $38,931,696, a 24% decline.

CBD 144

CBD Seed-To-Sale Food Access 144

CannaTech

JUNE 30, 2019

Patients over the age of 18 (excepting children with severe epilepsy). Neurological indications such as epilepsy, Parkinson’s. Severe epilepsy in minors. Israeli medical cannabis patients protesting outside of CannaTech Tel Aviv 2019 (photo by Ilyan Marshak). Registered by a specialist physician.

Patients 90

Patients Oil Epilepsy Strains 90

CannaMD

JULY 14, 2020

Patients with difficult-to-treat illnesses such as epilepsy , or children with autism spectrum disorder (ASD) , are all commonly prescribed multiple medications to treat complex symptoms. However, it’s not just older patients who encounter problems with polypharmacy. of patients were able to stop using benzodiazepines.

Marijuana 105

Marijuana Conditions Patients Epilepsy 105

Cannabis Chronicles

JANUARY 2, 2019

drug regulators approved the first marijuana-based pharmaceutical to treat kids with a form of epilepsy, and billions of investment dollars poured into cannabis companies. With buzz building across the globe, the momentum will continue into 2019. Even main street brands like Coca-Cola are considering joining the party. “I

Legalization 100

Legalization Research and Development Recreational Data 100

MassRoots

MARCH 25, 2019

On Monday, March 18, 2019, Gov. Newly sworn-in Governor Ron DeSantis officially ended the statewide ban on smokable forms of medical cannabis in Florida, making good on the promise he made to patients. DeSantis signed Senate Bill 182 “Medical Use of Marijuana” into law. Which conditions qualify for medical cannabis in Florida?

Patients 99

Patients Conditions Legislation Epilepsy 99

Cannabis Law Report

JULY 30, 2021

Fifty-nine-year old Dragoljub Mrdjic has suffered from epilepsy for most of his life. It was discovered in 2019 that the Jovanjica organic vegetable farm near the town of Stara Pazova was actually a front for an illegal marijuana plantation. I tried standard medicine, but there wasn’t much of a result.

Patients 105

Patients Oil Marijuana Medicine 105

The Cannigma

SEPTEMBER 28, 2021

In 2019, Ireland’s Minister for Health signed legislation to allow a pilot plan for medical cannabis, which launched in 2021 and is set to run for five years. Along with Sativex, the cannabis-based medicine Epidylolex is approved for use with specific conditions like severe forms of pediatric epilepsy and can be prescribed by a physician.

Law 97

Law Marijuana Treatment Epilepsy 97

CannaTech

APRIL 1, 2020

Hundreds of thousands of patients around the world rely on cannabis medicine to treat a range of conditions, including epilepsy, Parkinsons, cancer, PTSD, Crohn’s disease, autism, chronic pain and more. In 2019, I completed the Israel Ministry of Health’s cannabis curriculum for pharmacists.

Supply Chain 98

Supply Chain Chronic Pain Pharmaceutical Patients 98

The Cannigma

SEPTEMBER 28, 2021

In 2019, Ireland’s Minister for Health signed legislation to allow a pilot plan for medical cannabis, which launched in 2021 and is set to run for five years. Along with Sativex, the cannabis-based medicine Epidylolex is approved for use with specific conditions like severe forms of pediatric epilepsy and can be prescribed by a physician.

Law 96

Law Marijuana Treatment Epilepsy 96

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. The perception that CBD is a wonder-drug version of cannabis — particularly known for its uses to treat epilepsy — that doesn’t get you high. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

AUGUST 21, 2019

The watchdog refused to allow its national health service to prescribe medical cannabis for children with severe epilepsy because there is “not enough evidence it works”, a decision which angered campaigners and parents who said their children will suffer as a result. The final guideline is expected to be published in November 2019.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

Cannabis Law Report

JULY 7, 2022

January 2019. s patent directed to the use of cannabinoids, including cannabidiol (“CBD”), in the treatment of certain types of epilepsy. Sterne, Kessler, Goldstein & Fox P.L.L.C. Eleven of thirteen cannabis patent claims survive PTAB challenge. Insys Development Company, Inc. i] Insys Development Company, Inc. 36 (P.T.A.B.

Epilepsy 52

Epilepsy Pharmaceutical Treatment Cannabinoids 52

Veriheal

JULY 26, 2023

In 2019, Georgia’s General Assembly passed Georgia’s Hope Act, which legalized the regulated cultivation of marijuana in the State. Northwest Georgia News also revealed, “Separate from those dispensaries, the 2019 law also authorizes independent pharmacies to sell cannabis oil to eligible patients.”

Oil 98

Oil Patients Access THC 98

Cannabis Law Report

JUNE 5, 2019

30 May 2019. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. 30 May 2019. Google Translation. Call 02 644 8856/082 493 9890.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

The Cannigma

JULY 5, 2022

In-state cultivation and distribution weren’t legalized until 2019. In 2015, Georgia legalized possession of up 20 fl. oz of 5% or less THC oil for medical patients with qualifying conditions. But there were a myriad of problems with the rollout that persist today.

Law 119

Law Decriminalization Programs Patients 119

Cannabis Law Report

DECEMBER 9, 2019

Although official uses (outside of treatment for childhood epilepsy) have not been officially approved by the FDA, early results from research has resulted in consumers flocking to the compound of their own accord and at their own risk. Millions of individuals are reporting CBD having aided in helping them with: Anxiety.

Pets 45

Pets CBD Research and Development Epilepsy 45

NORML

MAY 24, 2019

The measure expands qualifying conditions to include all epilepsy and seizure disorders, multiple sclerosis, spasticity, terminal cancer, incurable neurological disorders (Alzheimer’s, Parkinson’s, Huntington’s, etc.), Click here to email your lawmakers in support of expungement.

Legislation 195

Legislation Hemp Access Patients 195

Veriheal

NOVEMBER 20, 2020

Though this idea did not gain enough traction to be written into law, the Governor did sign the Texas Compassionate Use Act, allowing low THC cannabis to be used for the treatment of epilepsy.

Legalization 98

Legalization Epilepsy Cannabis Legislation 98

The Joint Blog

JANUARY 31, 2021

The study is titled A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extract as complementary therapy: A case report. For the study researchers studied the effects of marijuana extracts in a fifteen-year-old who suffered from autism, anxiety, and controlled epilepsy. ml twice daily. Case presentation.

Epilepsy 62

Epilepsy Extraction Research and Development Clinical Trials 62

Veriheal

SEPTEMBER 27, 2021

Individuals with this condition have to find ways to deal with the fact that their immune system is attacking the protective sheath of nerve fiber surrounding the nerve cells, putting the body in a state of imbalance that results in muscle spasms, paralysis, disrupted bladder function, mental changes, depression, and even epilepsy.

Treatment 98

Treatment Patients Access Research and Development 98

Cannabis Law Report

MARCH 1, 2019

Broadcast: Fri 22 Feb 2019, 5:10pm. Featured: Michael Lambert, father of child with epilepsy. Carol Ireland, managing director, Epilepsy Action Australia. Experts say significant barriers to legal access have produced a failed system and are calling for an independent regulator. Duration: 3min 52sec. More Information.

Epilepsy 45

Epilepsy Medicine Cannabinoids Access 45